Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Clinical Advances in Hematology & Oncology : H&O|April 17, 2026
Is there an optimal sequential order to androgen receptor axis therapeutics?Jacob Alex, Julie N GraffDrugs & Aging|February 9, 2021
Next-Generation Androgen Receptor-Signaling Inhibitors for Prostate Cancer: Considerations for Older PatientsZizhen Feng, Julie N GraffResearch and Reports in Urology|December 13, 2016
Impact of enzalutamide on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectivesJia Luo, Julie N GraffExpert Review of Anticancer Therapy|July 31, 2015
Should docetaxel be administered earlier in prostate cancer therapy?Julie N Graff, Tomasz M BeerOncology (Williston Park, N.Y.)|June 21, 2015
Reducing Skeletal-Related Events in Metastatic Castration-Resistant Prostate CancerJulie N Graff, Tomasz M BeerDrugs & Aging|November 13, 2014
Pharmacotherapeutic management of metastatic, castration-resistant prostate cancer in the elderly: focus on non-chemotherapy agentsJulie N Graff, Tomasz M BeerCore Evidence|January 8, 2015
Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapyJulie N Graff, Erin D ChamberlainFederal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|September 10, 2020
Leveraging Veterans Health Administration Clinical and Research Resources to Accelerate Discovery and Testing in Precision OncologyJulie N Graff, Grant D HuangOncology (Williston Park, N.Y.)|April 18, 2016
Treatment of Nonmetastatic Castration-Resistant Prostate CancerJia Luo, Tomasz M Beer, Julie N GraffPageof 8